The digital payment technology provider took its overall funding past $225m, securing new capital from investors including Salesforce Ventures.

The computational pathology technology provider has added $25m to a round co-led by Johnson & Johnson Innovation – JJDC.

Allianz will collaborate on the development of new products with the digital financial services provider after supplying it with series C1 funding.

Qutoutiao’s literature platform subsidiary is raising series C financing and will use the cash to ramp up its content.

The workforce management software developer has been valued at more than $1bn in a $100m series C round backed by Workday.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Versant Ventures, which incubated the cell-based immunotherapy developer based on Harvard and Stanford research, has backed a $160m round.

Salesforce Ventures took part in a round that near tripled the valuation of the virtual events platform developer to $5.65bn in just four months.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Returning investor Leaps by Bayer was among the participants in the cell-based immunotherapy developer’s series C round having previously led a $250m round in 2019.